GABRIELLI, ARMANDO
 Distribuzione geografica
Continente #
NA - Nord America 246
EU - Europa 104
AS - Asia 48
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 401
Nazione #
US - Stati Uniti d'America 246
SE - Svezia 38
CN - Cina 29
IT - Italia 27
SG - Singapore 16
DE - Germania 11
GB - Regno Unito 10
RU - Federazione Russa 8
FI - Finlandia 4
AT - Austria 1
BJ - Benin 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
IE - Irlanda 1
IR - Iran 1
MD - Moldavia 1
MY - Malesia 1
NL - Olanda 1
TR - Turchia 1
Totale 401
Città #
Chandler 49
Nyköping 23
Fairfield 22
Woodbridge 18
Ashburn 16
Ann Arbor 14
Singapore 11
Houston 10
Seattle 10
Beijing 9
Cambridge 8
New York 7
Roxbury 7
Wilmington 7
Lawrence 6
Brooklyn 4
Des Moines 4
Genoa 4
Bari 3
Boardman 3
Dearborn 3
Hefei 3
Jacksonville 3
Monza 3
Bologna 2
Hebei 2
Helsinki 2
Inglewood 2
Milan 2
Nanjing 2
Princeton 2
San Diego 2
Tianjin 2
Amsterdam 1
Ardabil 1
Augusta 1
Chicago 1
Chisinau 1
Civitanova Marche 1
Cotonou 1
Dublin 1
Frankfurt am Main 1
Indiana 1
Jiaxing 1
Kuala Lumpur 1
Lanzhou 1
Leawood 1
London 1
Los Angeles 1
Madrid 1
Monmouth Junction 1
Munich 1
Nanchang 1
Nuremberg 1
Paris 1
Redwood City 1
Rome 1
Romola 1
San Mateo 1
Santa Clara 1
Shenyang 1
Shijiazhuang 1
São Paulo 1
Washington 1
Xian 1
Yiwu 1
Totale 298
Nome #
Validation of the classification criteria for cryoglobulinaemic vasculitis 105
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 70
null 63
Cancrini, Caterina, et al. "Clinical features and follow-up in patients with 22q11. 2 deletion syndrome." The Journal of pediatrics 164.6 (2014): 1475-1480. 49
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: Implications for risk and therapy 45
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 36
Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus. 31
null 20
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 6
Early administration of tofacitinib in COVID ‐19 pneumonitis: An open randomised controlled trial 6
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 4
Totale 435
Categoria #
all - tutte 2.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 4 7 6 3 4 15 2
2020/202155 6 5 1 4 4 5 2 5 1 6 8 8
2021/202266 0 2 2 3 9 11 0 5 3 7 9 15
2022/2023104 15 19 6 7 16 9 3 10 12 1 6 0
2023/202439 0 6 4 5 2 9 1 2 0 1 2 7
2024/202556 4 1 29 2 6 14 0 0 0 0 0 0
Totale 435